Zydus Lifesciences Ltd

NSE: ZYDUSLIFE · BSE: 532321 · Pharmaceuticals & Biotechnology · 88 announcements

Zydus Lifesciences Ltd news stories on ALFA NewsRead the news →

Share price: ₹1,199.50
Market cap: ₹1,20,698 Cr
Revenue (annual): ₹27,148 Cr
Net profit (annual): ₹5,040 Cr
P/E (TTM): 28.9×Sector 43.8×
Promoter holding: 75.01%+0.00% QoQ
FII holding: 7.05%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15 Oct 2026 11:30 IST NSE

Zydus Lifesciences Capacity Expansion: ₹190 Cr Investment

Zydus' JV with Sunshine Healthcare signed a BOI agreement to establish a pharma plant in Sri Lanka. Investment exceeds USD 20 million (~₹190 Cr), targeting 2028.

Value: ₹190.0 Cr

Open announcement → Read the filing ↗

Zydus Lifesciences Ltd by type

Business Update 10
Acquisition 10
Merger & Restructuring 10
Other Announcement 8
Legal & Regulatory 8
Earnings Call 7
Regulatory Approval 6
Financial Results 4
Management Change 4
Board Meeting Date 4
Product Launch 3
Results Update 2
Promoter Buying (Off-Market) 2
Annual General Meeting 2